The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities

Multikinase inhibitors (e.g. Sorafenib), phosphodiesterase-5 inhibitors (e.g. Tadalafil), and endothelin-1 receptor blockers (e.g. Macitentan) exert influential protection in a variety of animal models of cardiomyopathy; however, their effects on thyroxin-induced cardiomyopathy have never been inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Nancy S., Floyd, Kyle, Ahmed, Amany A. E., Mohler, Peter J., Janssen, Paul M. L., Elnakish, Mohammad T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833287/
https://www.ncbi.nlm.nih.gov/pubmed/27082116
http://dx.doi.org/10.1371/journal.pone.0153694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833287/
https://www.ncbi.nlm.nih.gov/pubmed/27082116
http://dx.doi.org/10.1371/journal.pone.0153694

Ejemplares similares